Hedepy, an online psychotherapy platform, has secured $1.89 million (€1.75 million) and completed its $4.17 million (€3.85 million) funding round. The company intends to use the funds to enhance its platform for preventative mental healthcare and to provide further support to corporate clients that use Hedepy for their employees.

Hedepy began online psychiatric services in 2023, provided by verified and qualified psychiatrists in partnership with Unicare Medical. Each associated professional, whether therapists or psychiatrists, must have the necessary skills, but there are still plenty of candidates. The company now has over 1,500 people on its waiting list in its operating nations. The platform also provides therapeutic services to workplaces and schools and an advanced self-help zone where people can focus on preventative mental healthcare. It has grown by over 200 per cent year-on-year, with more than 100,000 therapy sessions last year.

Speaking about the company, Co-founder & CEO of Hedepy, Lukáš Krčil, said:

The market is changing; we no longer have to explain as much why it is essential to take care of our mental health. Instead, we can focus on getting help to everyone who needs it.

The startup has been operating in the Czech market since 2020. The platform has grown into ten other European markets in four years, including Poland, Romania, Ukraine, Greece, and Finland. Hedepy is the market leader in five of these markets, providing more than 60% of its therapies abroad.

Gergő Iváncsics, Partner at Impact Ventures, stated:

Hedepy is exceptional in that it has not only managed to expand into eleven global markets in a short period but has also succeeded in them and continued to develop. The way they combine quality therapists with a self-help app is unique in Europe, and because of this, we believe they can soon become a regional leader.

For regular updates about Moodle, eLearning and edtech industry, please visit us regularly at https://lmsdaily.com. You can also like us on Facebook or follow us on Twitter, or Subscribe our YouTube Channel.